XML 21 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated statement of changes in equity/(deficit) - EUR (€)
€ in Millions
Total
Number of Ordinary Shares Outstanding
Share Capital
Treasury Shares
Other Paid in Capital
Other Reserves
Accumulated Deficit
Beginning balance (in shares) (After adoption of IFRS 16) at Dec. 31, 2018   180,856,081          
Beginning balance (After adoption of IFRS 16) at Dec. 31, 2018 € 2,076   € 0 € (77) € 3,801 € 875 € (2,523)
Loss for the year (186)           (186)
Other comprehensive income (loss) (111)         (111)  
Repurchases of ordinary shares (in shares)   (3,679,156)          
Repurchases of ordinary shares (433)     (433)      
Issuance of shares upon exercise of stock options and restricted stock units (in shares)   3,557,405          
Issuance of shares upon exercise of stock options, restricted stock units, and contingently issuable shares 154     140 14    
Issuance of shares upon exercise of, or net settlement of, warrants (in shares)   3,591,627          
Issuance of shares upon exercise of, or net settlement of, warrants 377       377    
Issuance of share-based compensation in conjunction with business combinations 13         13  
Restricted stock units withheld for employee taxes (6)         (6)  
Share-based compensation 127         127  
Income tax impact associated with share-based compensation 26         26  
Ending balance (in shares) (After adoption of IFRS 16) at Dec. 31, 2019   184,325,957          
Ending balance (After adoption of IFRS 16) at Dec. 31, 2019 2,037   0 (370) 4,192 924 (2,709)
Loss for the year (581)           (581)
Other comprehensive income (loss) 577         577  
Issuance of ordinary shares (in shares)   5,038,200          
Issuance of ordinary shares € 0            
Repurchases of ordinary shares (in shares) (5,038,200) (5,038,200)          
Repurchases of ordinary shares € 0            
Issuance of shares upon exercise of stock options and restricted stock units (in shares)   4,802,847          
Issuance of shares upon exercise of stock options, restricted stock units, and contingently issuable shares 319     195 124    
Issuance of shares upon exercise of, or net settlement of, warrants (in shares)   1,084,043          
Issuance of shares upon exercise of, or net settlement of, warrants 267       267    
Issuance of share-based compensation in conjunction with business combinations 0            
Restricted stock units withheld for employee taxes (29)         (29)  
Share-based compensation 181         181  
Income tax impact associated with share-based compensation 34         34  
Ending balance (in shares) at Dec. 31, 2020   190,212,847          
Ending balance at Dec. 31, 2020 2,805   0 (175) 4,583 1,687 (3,290)
Loss for the year (34)           (34)
Other comprehensive income (loss) (919)         (919)  
Reclassification of gain on sale of long term investments 0         (134) 134
Reclassification of tax effect of gain on sale of long term investments 0         30 (30)
Issuance of ordinary shares (in shares)   2,000,000          
Issuance of ordinary shares € 0            
Repurchases of ordinary shares (in shares) (2,458,234) (2,458,234)          
Repurchases of ordinary shares € (89)     (89)      
Issuance of shares upon exercise of stock options and restricted stock units (in shares)   2,397,198          
Issuance of shares upon exercise of stock options, restricted stock units, and contingently issuable shares 167     4 163    
Issuance of share-based compensation in conjunction with business combinations 0            
Restricted stock units withheld for employee taxes (54)         (54)  
Share-based compensation 222         222  
Income tax impact associated with share-based compensation 21         21  
Ending balance at Dec. 31, 2021 € 2,119   € 0 € (260) € 4,746 € 853 € (3,220)